Global Artificial Organ And Bionics Market By Type (Mechanical Bionics, And Electronic Bionics), By Application (Artificial Organs, Bionics ), By Region And Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends And Forecast 2022-2032
- Published date: May 2022
- Report ID: 13741
- Number of Pages: 342
- Format:
- keyboard_arrow_up
- 1. Artificial Organ And Bionics Market Introduction
- 1.1. Definition
- 1.2. Taxonomy
- 1.3. Research Scope
- 2. Executive Summary
- 2.1. Key Findings by Major Segments
- 2.2. Top strategies by Major Players
- 3. Global Artificial Organ And Bionics Market Overview
- 3.1. Artificial Organ And Bionics Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Opportunities
- 3.1.3. Restraints
- 3.1.4. Challenges
- 3.2. PESTLE Analysis
- 3.3. Opportunity Map Analysis
- 3.4. PORTER'S Five Forces Analysis
- 3.5. Market Competition Scenario Analysis
- 3.6. Product Life Cycle Analysis
- 3.7. Opportunity Orbits
- 3.8. Manufacturer Intensity Map
- 3.1. Artificial Organ And Bionics Market Dynamics
- 4. Global Artificial Organ And Bionics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
- 4.1. Global Artificial Organ And Bionics Market Analysis by Type: Introduction
- 4.2. Market Size and Forecast by Region
- 4.3. Mechanical Bionics
- 4.4. Electronic Bionics
- 5. Global Artificial Organ And Bionics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
- 5.1. Global Artificial Organ And Bionics Market Analysis by Application: Introduction
- 5.2. Market Size and Forecast by Region
- 5.3. Artificial Organs
- 5.4. Bionics
- 6. Global Artificial Organ And Bionics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
- 6.1. North America
- 6.1.1. North America Artificial Organ And Bionics Market: Regional Trend Analysis
- 6.1.1.1. US
- 6.1.1.2. Canada
- 6.1.1.3. Mexico
- 6.1.1. North America Artificial Organ And Bionics Market: Regional Trend Analysis
- 6.2.1. Europe
- 6.2.1. Europe Artificial Organ And Bionics Market: Regional Trend Analysis
- 6.2.1.1. Germany
- 6.2.1.2. France
- 6.2.1.3. UK
- 6.2.1.4. Russia
- 6.2.1.5. Italy
- 6.2.1.6. Spain
- 6.2.1.7. Rest of Europe
- 6.2.1. Europe Artificial Organ And Bionics Market: Regional Trend Analysis
- 6.3. Asia-Pacific
- 6.3.1. Asia-Pacific Artificial Organ And Bionics Market: Regional Trend Analysis
- 6.3.1.1. China
- 6.3.1.2. Japan
- 6.3.1.3. Korea
- 6.3.1.4. India
- 6.3.1.5. Rest of Asia
- 6.3.1. Asia-Pacific Artificial Organ And Bionics Market: Regional Trend Analysis
- 6.4. Latin America
- 6.4.1. Latin America Artificial Organ And Bionics Market: Regional Trend Analysis
- 6.4.1.1. Brazil
- 6.4.1.2. Argentina
- 6.4.1.3. Rest of Latin America
- 6.4.1. Latin America Artificial Organ And Bionics Market: Regional Trend Analysis
- 6.5. Middle East and Africa
- 6.5.1. Middle East and Africa Artificial Organ And Bionics Market: Regional Trend Analysis
- 6.5.1.1. GCC
- 6.5.1.2. South Africa
- 6.5.1.3. Israel
- 6.5.1.4. Rest of MEA
- 6.5.1. Middle East and Africa Artificial Organ And Bionics Market: Regional Trend Analysis
- 6.1. North America
- 7. Global Artificial Organ And Bionics Market Competitive Landscape, Market Share Analysis, and Company Profiles
- 7.1. Market Share Analysis
- 7.2. Company Profiles
- 7.3. Abiomed Inc.
- 7.3.1. Company Overview
- 7.3.2. Financial Highlights
- 7.3.3. Product Portfolio
- 7.3.4. SWOT Analysis
- 7.3.5. Key Strategies and Developments
- 7.4. Asahi Kasei Kuraray Medical Co. Ltd.
- 7.4.1. Company Overview
- 7.4.2. Financial Highlights
- 7.4.3. Product Portfolio
- 7.4.4. SWOT Analysis
- 7.4.5. Key Strategies and Developments
- 7.5. Thoratec Corporation
- 7.5.1. Company Overview
- 7.5.2. Financial Highlights
- 7.5.3. Product Portfolio
- 7.5.4. SWOT Analysis
- 7.5.5. Key Strategies and Developments
- 7.6. WorldHeart Corp.
- 7.6.1. Company Overview
- 7.6.2. Financial Highlights
- 7.6.3. Product Portfolio
- 7.6.4. SWOT Analysis
- 7.6.5. Key Strategies and Developments
- 7.7. Gambro AB
- 7.7.1. Company Overview
- 7.7.2. Financial Highlights
- 7.7.3. Product Portfolio
- 7.7.4. SWOT Analysis
- 7.7.5. Key Strategies and Developments
- 7.8. Biomet Inc.
- 7.8.1. Company Overview
- 7.8.2. Financial Highlights
- 7.8.3. Product Portfolio
- 7.8.4. SWOT Analysis
- 7.8.5. Key Strategies and Developments
- 7.9. Cochlear Ltd.
- 7.9.1. Company Overview
- 7.9.2. Financial Highlights
- 7.9.3. Product Portfolio
- 7.9.4. SWOT Analysis
- 7.9.5. Key Strategies and Developments
- 7.10. Berlin Heart Gmbh
- 7.10.1. Company Overview
- 7.10.2. Financial Highlights
- 7.10.3. Product Portfolio
- 7.10.4. SWOT Analysis
- 7.10.5. Key Strategies and Developments
- 7.11. Ekso Bionics
- 7.11.1. Company Overview
- 7.11.2. Financial Highlights
- 7.11.3. Product Portfolio
- 7.11.4. SWOT Analysis
- 7.11.5. Key Strategies and Developments
- 7.12. Medtronic Inc.
- 7.12.1. Company Overview
- 7.12.2. Financial Highlights
- 7.12.3. Product Portfolio
- 7.12.4. SWOT Analysis
- 7.12.5. Key Strategies and Developments
- 7.13. Lifenet Health
- 7.13.1. Company Overview
- 7.13.2. Financial Highlights
- 7.13.3. Product Portfolio
- 7.13.4. SWOT Analysis
- 7.13.5. Key Strategies and Developments
- 7.14. Heartware International Inc.
- 7.14.1. Company Overview
- 7.14.2. Financial Highlights
- 7.14.3. Product Portfolio
- 7.14.4. SWOT Analysis
- 7.14.5. Key Strategies and Developments
- 7.15. Jarvik Heart Inc.
- 7.15.1. Company Overview
- 7.15.2. Financial Highlights
- 7.15.3. Product Portfolio
- 7.15.4. SWOT Analysis
- 7.15.5. Key Strategies and Developments
- 7.16. Walk Inc.
- 7.16.1. Company Overview
- 7.16.2. Financial Highlights
- 7.16.3. Product Portfolio
- 7.16.4. SWOT Analysis
- 7.16.5. Key Strategies and Developments
- 7.17. Ossur
- 7.17.1. Company Overview
- 7.17.2. Financial Highlights
- 7.17.3. Product Portfolio
- 7.17.4. SWOT Analysis
- 7.17.5. Key Strategies and Developments
- 7.18. Boston Scientific Corporation
- 7.18.1. Company Overview
- 7.18.2. Financial Highlights
- 7.18.3. Product Portfolio
- 7.18.4. SWOT Analysis
- 7.18.5. Key Strategies and Developments
- 7.19. Sorin S.P.A.
- 7.19.1. Company Overview
- 7.19.2. Financial Highlights
- 7.19.3. Product Portfolio
- 7.19.4. SWOT Analysis
- 7.19.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- 1. Artificial Organ And Bionics Market Introduction
- Zimmer Biomet
- Medtronic
- Abbott Laboratories
- ABIOMED INC
- Berlin Heart Gmbh
- Biomet, Inc.
- Boston Scientific Corporation Company Profile
- Edward Lifesciences Corporation
- Ekso Bionics
- Heartware International, Inc.
- Iwalk, Inc.
- Jarvik Heart, Inc.
- SynCardia Systems, LLC.
- Other Key Players
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
---|---|---|---|
e-Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |